Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.170
+0.030 (2.63%)
At close: Mar 9, 2026, 4:00 PM EDT
1.270
+0.100 (8.55%)
After-hours: Mar 9, 2026, 7:49 PM EDT
Artelo Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -12.88 | -9.83 | -9.29 | -10.08 | -12.11 | |
| Other Amortization | 0.21 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | - | -0.28 | -0.64 | -0.21 | -0.02 | |
| Stock-Based Compensation | 1.14 | 0.82 | 1.02 | 2.46 | 2.8 | |
| Other Operating Activities | 1.26 | 0.03 | 0.04 | 0.04 | 0.03 | |
| Change in Accounts Payable | 1.59 | 0.48 | 0.27 | 0.02 | 1.5 | |
| Change in Other Net Operating Assets | 0.16 | 0.43 | 0.39 | -0.24 | -0.21 | |
| Operating Cash Flow | -8.52 | -8.35 | -8.21 | -8.01 | -8 | |
| Investment in Securities | - | 7.77 | 3.51 | 2.96 | -30.1 | |
| Other Investing Activities | -0.06 | - | - | - | - | |
| Investing Cash Flow | -0.06 | 7.77 | 3.51 | 2.96 | -30.1 | |
| Short-Term Debt Issued | 0.61 | - | - | - | - | |
| Total Debt Issued | 0.61 | - | - | - | - | |
| Short-Term Debt Repaid | -0.02 | - | - | - | - | |
| Total Debt Repaid | -0.02 | - | - | - | -0 | |
| Net Debt Issued (Repaid) | 0.58 | - | - | - | -0 | |
| Issuance of Common Stock | 6.28 | 0.11 | 0.57 | - | 54.79 | |
| Financing Cash Flow | 6.87 | 0.11 | 0.57 | - | 54.78 | |
| Foreign Exchange Rate Adjustments | -0.02 | -0.01 | 0.06 | -0.22 | -0.08 | |
| Net Cash Flow | -1.74 | -0.48 | -4.07 | -5.27 | 16.6 | |
| Free Cash Flow | -8.52 | -8.35 | -8.21 | -8.01 | -8 | |
| Free Cash Flow Per Share | -8.28 | -15.55 | -16.64 | -16.96 | -21.53 | |
| Levered Free Cash Flow | -4.17 | -4.7 | -4.64 | -4.31 | - | |
| Unlevered Free Cash Flow | -4.2 | -4.7 | -4.64 | -4.3 | - | |
| Change in Working Capital | 1.75 | 0.91 | 0.66 | -0.22 | 1.29 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.